As of 2024-12-13, the EV/EBITDA ratio of Neurones SA (NRO.PA) is 11.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NRO.PA's latest enterprise value is 1,059.74 mil EUR. NRO.PA's TTM EBITDA according to its financial statements is 91.27 mil EUR. Dividing these 2 quantities gives us the above NRO.PA EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 9.8x | 9.0x |
| Forward P/E multiples | 10.4x - 12.2x | 11.4x |
| Fair Price | 30.15 - 46.58 | 38.33 |
| Upside | -30.5% - 7.5% | -11.6% |
| Date | EV/EBITDA |
| 2024-12-09 | 11.58 |
| 2024-12-06 | 11.93 |
| 2024-12-05 | 11.82 |
| 2024-12-04 | 11.86 |
| 2024-12-03 | 12.10 |
| 2024-12-02 | 11.76 |
| 2024-11-29 | 12.02 |
| 2024-11-28 | 12.04 |
| 2024-11-27 | 11.97 |
| 2024-11-26 | 12.12 |
| 2024-11-25 | 12.25 |
| 2024-11-22 | 12.16 |
| 2024-11-21 | 12.05 |
| 2024-11-20 | 12.28 |
| 2024-11-19 | 12.18 |
| 2024-11-18 | 12.05 |
| 2024-11-15 | 12.05 |
| 2024-11-14 | 12.08 |
| 2024-11-13 | 12.32 |
| 2024-11-12 | 12.30 |
| 2024-11-11 | 12.37 |
| 2024-11-08 | 12.32 |
| 2024-11-07 | 12.41 |
| 2024-11-06 | 12.25 |
| 2024-11-05 | 12.05 |
| 2024-11-04 | 12.33 |
| 2024-11-01 | 12.34 |
| 2024-10-31 | 12.48 |
| 2024-10-30 | 12.53 |
| 2024-10-29 | 12.53 |
| 2024-10-28 | 12.69 |
| 2024-10-25 | 12.65 |
| 2024-10-24 | 12.63 |
| 2024-10-23 | 12.50 |
| 2024-10-22 | 12.66 |
| 2024-10-21 | 12.53 |
| 2024-10-18 | 12.32 |
| 2024-10-17 | 12.08 |
| 2024-10-16 | 11.86 |
| 2024-10-15 | 11.80 |
| 2024-10-14 | 11.80 |
| 2024-10-11 | 11.86 |
| 2024-10-10 | 11.86 |
| 2024-10-09 | 11.89 |
| 2024-10-08 | 11.92 |
| 2024-10-07 | 11.93 |
| 2024-10-04 | 11.89 |
| 2024-10-03 | 11.90 |
| 2024-10-02 | 11.89 |
| 2024-10-01 | 11.93 |